96% REACHED DEPRESSION REMISSION*
8 Weeks • Randomized • Double-Blind • Placebo-Controlled
Researchers studied saffron in breastfeeding mothers experiencing mild-to-moderate postpartum depression.
At the end of the 8-week study, 96% of participants receiving saffron met the study's remission criterion compared with 43% receiving placebo.
Study dose: 30 mg saffron/day
SOURCE
Tabeshpour J, et al. A double-blind, randomized, placebo-controlled trial of saffron stigma (Crocus sativus L.) in mothers suffering from mild-to-moderate postpartum depression. Phytomedicine. 2017;36:145–152.